COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge - PubMed https://t.co/VKkPmlXLnj
6 followers
1,827 followers
@ShannonB @judetigger @StevenFEuro I’m not been a practicing medic for 20y (!?) but I’ve read 9 months after last dose gives a good chance of B cell recovery and therefore vaccine response. I imagine it would depend on underlying disease though, eg autoimm
2,446 followers
127 followers
RT @crwequine: @fitterhappierAJ In Tcells, NFATc1/2 are dispensable for inflammatory reactivity but are req for effector differentiation.…